Posts by: Patricia Inacio PhD

Patricia Inacio PhD

Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.

January 26, 2017

Higher Levels of Autoantibodies in Gaucher Patients Not Linked to Autoimmune Diseases, Study Finds

News

A multicenter study shows that people with type 1 Gaucher disease (GD) may have higher levels of serum autoantibodies, but these patients showed no clinical signs of autoimmune disorders. The ... Read more

January 17, 2017

Noninvasive Elastography May Help in Diagnosis of Gaucher Disease Patients

News

Noninvasive techniques measuring shear wave velocity in body tissues show potential at distinguishing Gaucher disease patients from other diseases with common symptoms, such as enlarged spleen. The study, “Are transient and shear ... Read more

January 13, 2017

GD Patients Reach Expected Height Regardless of Enzyme Replacement Therapy, Study Shows

News

Enzyme replacement therapy (ERT) in Gaucher disease patients has no significant impact on patients’ final height, suggests a small group retrospective study. The study, “Growth and final height of children ... Read more

December 13, 2016

Specific Type of Cell Stress May Be Linked to Development of Gaucher Disease, Study Says

News

New research has found that certain cells in Gaucher disease patients exhibit a specific type of tension called endoplasmic reticulum (ER) stress, which may be linked to the development of the ... Read more

December 8, 2016December 8, 2016

Case Study Calls Attention to Gallbladder Stones in People with Gaucher Type 1

News

Patients with Gaucher disease type 1 are at an increased risk of gallbladder stones, a case report reports. The condition is often safely resolved with minimally invasive surgery, but authors highlight that Gaucher ... Read more

November 22, 2016November 22, 2016

Taliglucerase Alfa Therapy is Safe for Certain Children with Gaucher Disease

News

The enzyme replacement therapy based on taliglucerase alfa has shown a sustained safety profile accompanied by long-term effectiveness in children with Gaucher disease (GD). The study “Long-term safety and efficacy ... Read more

November 3, 2016November 3, 2016

Unusual Movement Disorder Seen in Group of Gaucher Type 3 Patients in Sweden

News

A Swedish group of Gaucher patients showed clinical features never previously reported in this disease — a rapid and repetitive dystonia-like hyperkinetic movement disorder that may be unique to this group of people, researchers reported. ... Read more

July 21, 2016

Defenses Against Oxidative Stress Elevated in Gaucher Disease Type I Patients

News

Patients with Gaucher disease (GD) exhibit higher levels of several markers of antioxidant defense compared to healthy controls, a finding that highlights the alterations associated with the disease and the mechanisms ... Read more

June 16, 2016

Anti-Drug Antibodies Develop in Just a Fraction of Gaucher Patients Treated with Enzyme Replacement Therapy, Study Shows

News

Researchers conducted an enzyme replacement therapy study with a group of Gaucher disease patients and found just a small fraction of patients developed anti-drug antibodies. And, no correlation between antibody development and impaired ... Read more

May 17, 2016May 17, 2016

Neuronopathic Gaucher Disease in Egypt Leads to Different Clinical Outcomes in Long-term Patient Study

News

In a study involving an Egyptian cohort of patients with neuronopathic Gaucher disease, researchers observed that patients show diverse clinical outcomes that are markedly different from those exhibited by patients in other countries. The results ... Read more